333 related articles for article (PubMed ID: 12971795)
41. Evaluation of the toxic potentials of a new camptothecin anticancer agent CKD-602 on fertility and early embryonic development in rats.
Chung MK; Han SS; Kim JC
Regul Toxicol Pharmacol; 2006 Aug; 45(3):273-81. PubMed ID: 16814440
[TBL] [Abstract][Full Text] [Related]
42. Clindamycin-induced Maculopapular Exanthema with Preferential Involvement of Striae Distensae: A Koebner phenomenon?
Monteagudo B; Cabanillas M; Iriarte P; Ramírez-Santos A; León-Muinos E; González-Vilas D; Suárez-Amor Ó
Acta Dermatovenerol Croat; 2018 Apr; 26(1):61-63. PubMed ID: 29782303
[TBL] [Abstract][Full Text] [Related]
43. Tolerance induced by low dose D-penicillamine in the brown Norway rat model of drug-induced autoimmunity is immune-mediated.
Masson MJ; Uetrecht JP
Chem Res Toxicol; 2004 Jan; 17(1):82-94. PubMed ID: 14727922
[TBL] [Abstract][Full Text] [Related]
44. Randomized, controlled study of the effects of a short course of prednisone on the incidence of rash associated with nevirapine in patients infected with HIV-1.
Montaner JS; Cahn P; Zala C; Casssetti LI; Losso M; Hall DB; Wruck J; McDonough M; Gigliotti M; Robinson PA;
J Acquir Immune Defic Syndr; 2003 May; 33(1):41-6. PubMed ID: 12792354
[TBL] [Abstract][Full Text] [Related]
45. Mononuclear cell thyroiditis in rats with graft-versus-host disease.
Fujiwara K; Peszkowski MJ; Larsson A; Yamasaki A; Toda S; Watanabe T
J Pathol; 1995 Mar; 175(3):349-55. PubMed ID: 7745502
[TBL] [Abstract][Full Text] [Related]
46. Frequency of cutaneous reactions on rechallenge with nevirapine and delavirdine.
Gangar M; Arias G; O'Brien JG; Kemper CA
Ann Pharmacother; 2000; 34(7-8):839-42. PubMed ID: 10928391
[TBL] [Abstract][Full Text] [Related]
47. Lamotrigine rechallenge after a skin rash. A combined study of open cases and a meta-analysis.
Serrani Azcurra DJ
Rev Psiquiatr Salud Ment; 2013; 6(4):144-9. PubMed ID: 23084805
[TBL] [Abstract][Full Text] [Related]
48. [Cutaneous, hepatic and hematologic manifestations due to nevirapine: DRESS syndrome?].
Sissoko D; Ajana F; de la Tribonnière X; Baclet V; Mouton Y
Presse Med; 2000 May 27-Jun 3; 29(19):1041-2. PubMed ID: 10874910
[TBL] [Abstract][Full Text] [Related]
49. Characterization of a 2,4-dinitrochlorobenzene-induced chronic dermatitis model in rats.
Fujii Y; Takeuchi H; Sakuma S; Sengoku T; Takakura S
Skin Pharmacol Physiol; 2009; 22(5):240-7. PubMed ID: 19690449
[TBL] [Abstract][Full Text] [Related]
50. Nevirapine-induced liver lipid-SER inclusions and other ultrastructural aberrations.
Sastry J; Mohammed H; Campos MM; Uetrecht J; Abu-Asab M
Ultrastruct Pathol; 2018; 42(2):108-115. PubMed ID: 29424579
[TBL] [Abstract][Full Text] [Related]
51. Endothelial damage in all types of T-lymphocyte-mediated drug-induced eruptions.
Verneuil L; Leboeuf C; Vidal JS; Ratajczak P; Comoz F; Ameisen JC; Janin A
Arch Dermatol; 2011 May; 147(5):579-84. PubMed ID: 21576578
[TBL] [Abstract][Full Text] [Related]
52. Bacterial lipopolysaccharides induce peripheral nerve disturbances in rats that mimic human immune-mediated polyneuropathies.
Brown RF; Jackson GD; Martin T; Westbrook RF
Lab Anim Sci; 1997 Aug; 47(4):354-61. PubMed ID: 9306308
[TBL] [Abstract][Full Text] [Related]
53. [Alarm signs in drug-induced skin reactions].
Schmied-Dufour C; Schmied E
Ther Umsch; 1993 Jan; 50(1):20-2. PubMed ID: 8378862
[TBL] [Abstract][Full Text] [Related]
54. Drug-induced rash: nuisance or threat?
Wick JY
Consult Pharm; 2013 Mar; 28(3):160-6. PubMed ID: 23462025
[TBL] [Abstract][Full Text] [Related]
55. Systemic drug-related intertriginous and flexural exanthema (SDRIFE).
Elmariah SB; Cheung W; Wang N; Kamino H; Pomeranz MK
Dermatol Online J; 2009 Aug; 15(8):3. PubMed ID: 19891911
[TBL] [Abstract][Full Text] [Related]
56. Prediction of a new drug's potential to cause idiosyncratic reactions.
Uetrecht J
Curr Opin Drug Discov Devel; 2001 Jan; 4(1):55-9. PubMed ID: 11727323
[TBL] [Abstract][Full Text] [Related]
57. Influence of alkalinization of glutaraldehyde biocidal solutions on acute toxicity, primary irritancy, and skin sensitization.
Ballantyne B; Myers RC; Blaszcak DL
Vet Hum Toxicol; 1997 Dec; 39(6):340-6. PubMed ID: 9397502
[TBL] [Abstract][Full Text] [Related]
58. Sex differences in nevirapine rash.
Wong KH; Chan KC; Lee SS
Clin Infect Dis; 2001 Dec; 33(12):2096-8. PubMed ID: 11712101
[No Abstract] [Full Text] [Related]
59. Investigating the Mechanism of Trimethoprim-Induced Skin Rash and Liver Injury.
Cao Y; Bairam A; Jee A; Liu M; Uetrecht J
Toxicol Sci; 2021 Feb; 180(1):17-25. PubMed ID: 33394045
[TBL] [Abstract][Full Text] [Related]
60. Drug induced host factors which stimulate growth of residual leukemia in Lewis x Brown Norway F1 (LEW-BN) rats.
Burke PJ; Karp JE; Saylor PL
Cancer Res; 1986 Apr; 46(4 Pt 1):1813-6. PubMed ID: 3485014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
